Skip to content

Checked

Class IIDrug recallOngoing

Amlodipine and Olmesartan Medoxomil Tablets recall

Recalled by Ascend Laboratories, LLC of Bedminster, NJ · FDA report 07/29/2026

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Ongoing
Recall started
07/08/2026
Distribution
Nationwide

Reason for recall

Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
Lot and code info
Lot 25121311, expiry 3/31/2028
Quantity
6,192 bottles
Brand names
AMLODIPINE AND OLMESARTAN MEDOXOMIL
Recall number
D-0712-2026
Event ID
99385
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the USA

  • Nationwide

Recall timeline

  1. 07/08/2026Firm started the recall
  2. 07/20/2026FDA classified it as Class II
  3. 07/29/2026Published in the FDA enforcement report

More recalls from Ascend Laboratories

Frequently asked questions

Why was Amlodipine and Olmesartan Medoxomil Tablets recalled?
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
Nationwide in the USA
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 07/29/2026 · Do not rely on openFDA to make decisions regarding medical care